Skip to main content

Advertisement

SpringerLink
Log in

Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Intravesical mitomycin C (MMC) is commonly used to treat bladder cancer but is associated with local adverse effects. Here, we investigate the effects of MMC on release of urothelial mediators and production of inflammatory cytokines. Recovery and the effects of repeat treatment were also investigated. Urothelial cells were treated with MMC for 2 h at 37 °C. Immediately, 24 h and 7 days following MMC treatment, effects were assessed in terms of changes in ATP, acetylcholine and PGE2 release, and the presence of inflammatory cytokines and nitric oxide in incubation medium. Endpoints were also assessed 7 days after repeat MMC treatment. Immediately following MMC treatment at the clinical concentration (2 mg/mL), stretch-induced ATP release was significantly decreased, basal acetylcholine release was enhanced, while basal PGE2 was depressed and response to stretch increased. Twenty-four hours after treatment, basal acetylcholine was significantly increased ([MMC] ≥0.0002 mg/mL) and basal PGE2 enhanced (0.02 mg/mL). A 326-fold increase in interleukin-8 secretion and significant increase in nitric oxide release were also detected at 24 h. One week after single and repeat MMC treatment, urothelial ATP, acetylcholine and PGE2 had recovered while the increase in nitric oxide and interleukin-8 was still evident. These results indicate that urothelial mediator release is affected by MMC treatment with full recovery by 1 week. However, a concurrent increase in secretion of the inflammatory cytokine interleukin-8 and nitric oxide was also detected 24 h following treatment, which were still evident after the recovery period. These changes may play a role in the local adverse effects associated with intravesical MMC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Abou El Hassan MA, Verheul HM, Jorna AS, Schalkwijk C, van Bezu J, van der Vijgh WJ, Bast A (2003) The new cardioprotector monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. Br J Cancer 89:357–362. doi:10.1038/sj.bjc.6601022

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ (2010) Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 29:771–776. doi:10.1002/nau.20826

    Article  CAS  PubMed  Google Scholar 

  • Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ (2011) Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment. Eur Urol 59:264–271. doi:10.1016/j.eururo.2010.10.035

    Article  CAS  PubMed  Google Scholar 

  • Andersson MC, Tobin G, Giglio D (2008) Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol 153:1438–1444. doi:10.1038/bjp.2008.6

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Aoki K, Hirayama A, Tanaka N, Yoneda T, Yoshida K, Fujimoto K, Hirao Y (2009) A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstruction. Biomed Res 30:343–347

    Article  CAS  PubMed  Google Scholar 

  • Apodaca G, Balestreire E, Birder LA (2007) The uroepithelial-associated sensory web. Kidney Int 72:1057–1064. doi:10.1038/sj.ki.5002439

    Article  CAS  PubMed  Google Scholar 

  • Aronsson P, Vesela R, Johnsson M, Tayem Y, Wsol V, Winder M, Tobin G (2014) Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat. BioMed Res Int 2014:359179. doi:10.1155/2014/359179

    Article  PubMed Central  PubMed  Google Scholar 

  • Birder LA (2005) More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Ren Physiol 289:F489–F495. doi:10.1152/ajprenal.00467.2004

    Article  CAS  Google Scholar 

  • Birder LA (2010) Urothelial signaling. Auton Neurosci 153:33–40. doi:10.1016/j.autneu.2009.07.005

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Birder LA, Apodaca G, De Groat WC, Kanai AJ (1998) Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 275:F226–F229

    CAS  PubMed  Google Scholar 

  • Birder LA, Kanai AJ, Cruz F, Moore K, Fry CH (2010) Is the urothelium intelligent? Neurourol Urodyn 29:598–602. doi:10.1002/nau.20914

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Burnstock G (2011) Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 107:192–204. doi:10.1111/j.1464-410X.2010.09926.x

    Article  CAS  PubMed  Google Scholar 

  • Bustamante S, Orensanz LM, Recio P, Carballido J, Garcia-Sacristan A, Prieto D, Hernandez M (2010) Functional evidence of nitrergic neurotransmission in the human urinary bladder neck. Neurosci Lett 477:91–94. doi:10.1016/j.neulet.2010.04.040

    Article  CAS  PubMed  Google Scholar 

  • Cheng Y, Mansfield KJ, Sandow SL, Sadananda P, Burcher E, Moore KH (2011) Porcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release. Front Pharmacol 2:27. doi:10.3389/fphar.2011.00027

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chou SF, Chang SW, Chuang JL (2007) Mitomycin C upregulates IL-8 and MCP-1 chemokine expression via mitogen-activated protein kinases in corneal fibroblasts. Invest Ophth Vis Sci 48:2009–2016. doi:10.1167/Iovs.06-0835

    Article  Google Scholar 

  • Cockayne DA et al (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011–1015. doi:10.1038/35039519

    Article  CAS  PubMed  Google Scholar 

  • Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F (2012) Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study. Eur Urol 62:797–802. doi:10.1016/j.eururo.2012.05.032

    Article  CAS  PubMed  Google Scholar 

  • Dalton JT, Wientjes MG, Badalament RA, Drago JR, Au JL (1991) Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res 51:5144–5152

    CAS  PubMed  Google Scholar 

  • de Boer EC, Somogyi L, de Ruiter GJ, de Reijke TM, Kurth KH, Schamhart DH (1997) Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer. Urol Res 25:31–34

    Article  PubMed  Google Scholar 

  • de Jongh R, van Koeveringe GA, van Kerrebroeck PE, Markerink-van Ittersum M, de Vente J, Gillespie JI (2007) The effects of exogenous prostaglandins and the identification of constitutive cyclooxygenase I and II immunoreactivity in the normal guinea pig bladder. BJU Int 100:419–429. doi:10.1111/j.1464-410X.2007.07011.x

    Article  PubMed  Google Scholar 

  • Dokita S, Morgan WR, Wheeler MA, Yoshida M, Latifpour J, Weiss RM (1991) NG-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle. Life Sci 48:2429–2436

    Article  CAS  PubMed  Google Scholar 

  • Duque JL, Loughlin KR (2000) An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy. Urol Clin N Am 27:125–135

    Article  CAS  Google Scholar 

  • Ehren I, Hosseini A, Herulf M, Lundberg JO, Wiklund NP (1999) Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: a novel minimally invasive method. Urology 54:264–267

    Article  CAS  PubMed  Google Scholar 

  • Elmamoun MH, Christmas TJ, Woodhouse CR (2014) Destruction of the bladder by single dose mitomycin C for low-stage transitional cell carcinoma (TCC)—avoidance, recognition, management and consent. BJU Int 113:E34–E38. doi:10.1111/bju.12340

    Article  CAS  PubMed  Google Scholar 

  • Giglio D, Ryberg AT, To K, Delbro DS, Tobin G (2005) Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats. Auton Neurosci 122:9–20. doi:10.1016/j.autneu.2005.07.005

    Article  CAS  PubMed  Google Scholar 

  • Gillespie JI, Drake MJ (2004) The actions of sodium nitroprusside and the phosphodiesterase inhibitor dipyridamole on phasic activity in the isolated guinea-pig bladder. BJU Int 93:851–858. doi:10.1111/j.1464-410X.2003.04727.x

    Article  CAS  PubMed  Google Scholar 

  • Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC, Birder LA (2007) Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci 80:2298–2302. doi:10.1016/j.lfs.2007.02.010

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hayashi Y et al (2009) Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am J Physiol Regul Int Comp Physiol 296:R1661–R1670. doi:10.1152/ajpregu.91054.2008

    Article  CAS  Google Scholar 

  • Heinrich M, Oberbach A, Schlichting N, Stolzenburg JU, Neuhaus J (2011) Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS One 6:e20792. doi:10.1371/journal.pone.0020792

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kamat AM, Lamm DL (2000) Intravesical therapy for bladder cancer. Urology 55:161–168

    Article  CAS  PubMed  Google Scholar 

  • Kanai A et al (2007) Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists. Am J Physiol Ren Physiol 292:F1065–F1072. doi:10.1152/ajprenal.00229.2006

    Article  CAS  Google Scholar 

  • Kang SH, Chess-Williams R, Anoopkumar-Dukie S, McDermott C (2013) Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin. Eur J Pharmacol 700:102–109. doi:10.1016/j.ejphar.2012.11.053

    Article  CAS  PubMed  Google Scholar 

  • Koskela LR, Poljakovic M, Ehren I, Wiklund NP, de Verdier PJ (2012) Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer. Nitric Oxide Biol Chem Off J Nitric Oxide Soc 27:185–191. doi:10.1016/j.niox.2012.07.001

    Article  CAS  Google Scholar 

  • Koya MP, Simon MA, Soloway MS (2006) Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 175:2004–2010. doi:10.1016/S0022-5347(06)00264-3

    Article  PubMed  Google Scholar 

  • Kullmann FA, Artim D, Beckel J, Barrick S, de Groat WC, Birder LA (2008) Heterogeneity of muscarinic receptor-mediated Ca2+ responses in cultured urothelial cells from rat. Am J Physiol Ren Physiol 294:F971–F981. doi:10.1152/ajprenal.00313.2007

    Article  CAS  Google Scholar 

  • Kumar V, Chapple CR, Rosario D, Tophill PR, Chess-Williams R (2010) In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 57:1087–1092. doi:10.1016/j.eururo.2009.11.042

    Article  PubMed  Google Scholar 

  • Kumar V, Chapple CR, Surprenant AM, Chess-Williams R (2007) Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation. J Urol 178:1533–1536. doi:10.1016/j.juro.2007.05.116

    Article  CAS  PubMed  Google Scholar 

  • Logadottir Y, Delbro D, Fall M, Gjertsson I, Jirholt P, Lindholm C, Peeker R (2014) Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C. J Urol 192:1564–1568. doi:10.1016/j.juro.2014.04.099

    Article  CAS  PubMed  Google Scholar 

  • Logadottir YR, Ehren I, Fall M, Wiklund NP, Peeker R, Hanno PM (2004) Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol 171:1148–1150. doi:10.1097/01.ju.0000110501.96416.40, discussion 1150-1141

    Article  CAS  PubMed  Google Scholar 

  • Logan C, Brown M, Hayne D (2012) Intravesical therapies for bladder cancer—indications and limitations. BJU Int 110(Suppl 4):12–21. doi:10.1111/j.1464-410X.2012.11619.x

    Article  CAS  PubMed  Google Scholar 

  • Lundberg JO et al (1996) Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 48:700–702. doi:10.1016/S0090-4295(96)00423-2

    Article  CAS  PubMed  Google Scholar 

  • Maggi CA et al (1988) Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur J Pharmacol 145:105–112

    Article  CAS  PubMed  Google Scholar 

  • Mansfield KJ, Hughes JR (2014a) Effect of inflammatory mediators on ATP release of human urothelial RT4 cells. BioMed Res Int 2014:182862. doi:10.1155/2014/182862

    PubMed Central  PubMed  Google Scholar 

  • Mansfield KJ, Hughes JR (2014b) P2Y receptor modulation of ATP release in the urothelium. BioMed Res Int 2014:830374. doi:10.1155/2014/830374

    PubMed Central  PubMed  Google Scholar 

  • McDermott C, Chess-Williams R, Grant GD, Perkins AV, McFarland AJ, Davey AK, Anoopkumar-Dukie S (2012) Effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viability. J Urol 187:1087–1093. doi:10.1016/j.juro.2011.10.129

    Article  CAS  PubMed  Google Scholar 

  • Moon A (2002) Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro. BJU Int 89:942–949

    Article  CAS  PubMed  Google Scholar 

  • Moro C, Leeds C, Chess-Williams R (2012) Contractile activity of the bladder urothelium/lamina propria and its regulation by nitric oxide. Eur J Pharmacol 674:445–449. doi:10.1016/j.ejphar.2011.11.020

    Article  CAS  PubMed  Google Scholar 

  • Nomiya M et al (2012) Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn 31:185–189. doi:10.1002/nau.21191

    Article  CAS  PubMed  Google Scholar 

  • Pouya M, Opsomer RJ, Wese FX, Saleh M, Donnay M, Van Cangh PJ (1996) Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports. Acta Urol Belg 64:47–53

    CAS  PubMed  Google Scholar 

  • Souslova V et al (2000) Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407:1015–1017. doi:10.1038/35039526

    Article  CAS  PubMed  Google Scholar 

  • Tanaka I, Nagase K, Tanase K, Aoki Y, Akino H, Yokoyama O (2011) Modulation of stretch evoked adenosine triphosphate release from bladder epithelium by prostaglandin E(2). J Urol 185:341–346. doi:10.1016/j.juro.2010.09.042

    Article  CAS  PubMed  Google Scholar 

  • Thrasher JB, Crawford ED (1992) Complications of intravesical chemotherapy. Urol Clin N Am 19:529–539

    CAS  Google Scholar 

  • Wientjes MG, Badalament RA, Wang RC, Hassan F, Au JL (1993) Penetration of mitomycin C in human bladder. Cancer Res 53:3314–3320

    CAS  PubMed  Google Scholar 

  • Wientjes MG, Dalton JT, Badalament RA, Drago JR, Au JL (1991) Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res 51:4347–4354

    CAS  PubMed  Google Scholar 

  • Wyndaele JJ, De Wachter S (2003) The basics behind bladder pain: a review of data on lower urinary tract sensations. Int J Urol Off J Jpn Urol Assoc 10(Suppl):S49–S55

    Google Scholar 

  • Yokoyama O (2010) Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats. Neurourol Urodyn 29:107–111. doi:10.1002/nau.20746

    Article  CAS  PubMed  Google Scholar 

  • Yoshimura N, Seki S, Chancellor MB, de Groat WC, Ueda T (2002) Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology 59:61–67

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by a project grant from Cancer Council Queensland and the National Health and Medical Research Council of Australia (527502).

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland, 4229, Australia

    Sung Hyun Kang, Russ Chess-Williams & Catherine McDermott

  2. School of Pharmacy, Griffith University, Gold Coast, Queensland, 4222, Australia

    Shailendra Anoopkumar-Dukie

  3. Griffith Health Institute, Griffith University, Gold Coast, Queensland, 4222, Australia

    Shailendra Anoopkumar-Dukie

Authors
  1. Sung Hyun Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Russ Chess-Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shailendra Anoopkumar-Dukie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine McDermott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine McDermott.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, S.H., Chess-Williams, R., Anoopkumar-Dukie, S. et al. Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment. Naunyn-Schmiedeberg's Arch Pharmacol 388, 781–791 (2015). https://doi.org/10.1007/s00210-015-1092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-015-1092-7

Keywords

Search

Navigation